7464 related articles for article (PubMed ID: 2720888)
1. Ionic titanocene complexes: a new type of antitumor agent.
Köpf-Maier P; Neuse E; Klapötke T; Köpf H
Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumors.
Köpf-Maier P; Klapötke T
Arzneimittelforschung; 1989 Apr; 39(4):488-90. PubMed ID: 2751735
[TBL] [Abstract][Full Text] [Related]
3. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
[TBL] [Abstract][Full Text] [Related]
4. Ionic rhenocene derivatives with antitumor activity.
Köpf-Maier P; Klapötke T
Cancer Chemother Pharmacol; 1992; 29(5):361-6. PubMed ID: 1551174
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of titanocene amino acid complexes.
Köpf-Maier P; Tornieporth-Oetting IC
Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states.
Köpf-Maier P; Klapötke T
J Cancer Res Clin Oncol; 1992; 118(3):216-21. PubMed ID: 1548287
[TBL] [Abstract][Full Text] [Related]
7. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
8. Tumor inhibition by titanocene complexes. Activity against B16 melanoma and colon 38 carcinoma.
Köpf-Maier P; Köpf H
Arzneimittelforschung; 1987 May; 37(5):532-4. PubMed ID: 3619974
[TBL] [Abstract][Full Text] [Related]
9. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.
Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E
J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505
[TBL] [Abstract][Full Text] [Related]
11. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
Valadares MC; Queiroz ML
Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
13. Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumors.
Köpf-Maier P; Klapötke T
Arzneimittelforschung; 1989 Mar; 39(3):369-71. PubMed ID: 2757661
[TBL] [Abstract][Full Text] [Related]
14. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
Köpf-Maier P
J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
[TBL] [Abstract][Full Text] [Related]
15. Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line.
Hernández R; Méndez J; Lamboy J; Torres M; Román FR; Meléndez E
Toxicol In Vitro; 2010 Feb; 24(1):178-83. PubMed ID: 19772913
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
Keppler BK; Schmähl D
Arzneimittelforschung; 1986 Dec; 36(12):1822-8. PubMed ID: 3566844
[TBL] [Abstract][Full Text] [Related]
17. Ferricenium complexes: a new type of water-soluble antitumor agent.
Köpf-Maier P; Köpf H; Neuse EW
J Cancer Res Clin Oncol; 1984; 108(3):336-40. PubMed ID: 6511806
[TBL] [Abstract][Full Text] [Related]
18. Antitumor titanium compounds.
Caruso F; Rossi M
Mini Rev Med Chem; 2004 Jan; 4(1):49-60. PubMed ID: 14754443
[TBL] [Abstract][Full Text] [Related]
19. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
20. Antitumor properties of organometallic metallocene complexes of tin and germanium.
Köpf-Maier P; Janiak C; Schumann H
J Cancer Res Clin Oncol; 1988; 114(5):502-6. PubMed ID: 3182909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
